Stockreport

CHMP Issues Positive Opinion Recommending Subcutaneous Formulation of Daratumumab for the Treatment of Patients with Multiple Myeloma

Genmab A/S - American Depositary Shares  (GMAB) 
PDF Company Announcement Committee for Medicinal Products for Human Use issued Positive Opinion for subcutaneous formulation of daratumumab for the treatment of patients wi [Read more]